Tag:
Chiesi Farmaceutici
Latest Headlines
Latest Headlines
Phenomix forges $191M pact for diabetes drug
San Diego-based Phenomix is getting a $28 million injection from Italy's Chiesi Farmaceutici in exchange for a commercialization deal for the diabetes drug dutogliptin (PHX1149) in Europe and several
Chiesi grabs majority stake in Cornerstone
Italy's Chiesi Farmaceutici will buy a 51 percent stake in Cornerstone Therapeutics, a respiratory drug developer, in a deal valued at $70 million. Investors quickly signalled their disapproval of
